Description
Verantos is a leader in generating high-validity real-world evidence (RWE) at scale, leveraging robust clinical narrative data and artificial intelligence technology. The platform is designed to accelerate clinical development, market access, medical affairs, pharmacovigilance, and regulatory initiatives by providing credible evidence with measured accuracy, completeness, and traceability.
The Verantos Evidence Platform is unique in its ability to generate high-validity RWE from the entire patient record, supporting all major therapeutic areas. It uses proprietary deep phenotyping technology and a federated data network to achieve the scale required for comprehensive evidence generation. This approach allows life sciences organizations to understand patient characteristics and behaviors, predict disease progression, and improve R&D investments.
Verantos offers products like the Pragmatic Registry, which provides disease-specific registries generated from routinely collected real-world data. These registries include clinically rich data from the entire patient record, incorporating variables rarely coded in structured data. The data is normalized and delivered in standardized OMOP CDM format, ready for use by clinicians, payers, and regulators.
The platform's AI engine is trained using deep phenotyping methodology to ensure accurate extraction of patient characteristics. It supports various workflows, including observational studies, clinical trial recruitment, regulatory and reimbursement processes, and value-based contracting. Verantos' high-validity RWE has been validated through commercial engagements with top life sciences firms and is recognized by the NIH, NSF, and FDA.
Verantos' commitment to data quality is evident in its direct relationships with US academic medical centers and community health systems, providing a broad and geographically diverse network. This ensures the generalizability and external validity of the data, making Verantos a preferred choice for high-validity RWE.
Verantos High-Quality Real-World Data's Core Features
High-validity real-world evidence generation
Deep phenotyping technology
Federated data network
Pragmatic Registry for disease-specific data
Standardized OMOP CDM format
AI engine for patient data extraction
Supports observational studies and clinical trials
Direct relationships with US health systems
Validated by NIH, NSF, and FDA
High data accuracy, completeness, and traceability
How to use Verantos High-Quality Real-World Data?
Configure: Set up the Verantos Evidence Platform
Use: Generate high-validity real-world evidence
Optimize: Leverage AI for accurate data extraction
Analyze: Utilize standardized data for research
Verantos High-Quality Real-World Data's Use Cases
- Clinical Development
- Market Access
- Regulatory Initiatives
- Pharmacovigilance
- Value-Based Contracting
- Observational Studies
- Clinical Trial Recruitment
- R&D Investment
- Disease Progression Prediction
- Patient Outcome Analysis
